HOME

Newsletter Subscription
Print

Identification and therapeutic targeting of common arrhythmia trigger mechanisms


Category

FP7 Project with U.S. partner

Short name and number

EUTrigTreat (241526)

Area

Health

Description

Arrhythmias are common manifestations of heart disease which frequently cause sudden cardiac death (SCD) or other devastating health problems. In Europe, prevention of SCD by device and drug therapy is expensive and increasingly strains public health resources due to a growing population at risk. However, identification of patients at increased risk for SCD is ineffective, and SCD prevention strategies are not directed at the underlying risk mechanisms.

Participating Countries

Belgium, France, Germany, Greece, Italy, The Netherlands, United Kingdom, United States and Switzerland.

Name of US Partner

University of Maryland Biotechnology Institute

Contact

UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (DE)

See more

BILAT-USA (Grant Agreement no: 244434) and Link2US (Grant Agreement no: 244371) Projects are co-funded by the European Union’s Capacities Programme on International Cooperation under the 7th Framework Programme for Research and Technological Cooperation.